![]() |
![]() |
FDA Home Page | Search
FDA Site | FDA A-Z Index | Contact
FDA
![]()
Food and Drug Administration
Office of Public Affairs
5600 Fishers Lane
Rockville, MD 20857
This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.
![]() |
October 30, 2005 |
![]() |
|||
|---|---|---|---|---|---|
FDA Official and Title |
Date and Site |
Other FDA Participants |
Non-FDA Participants |
Subject |
|
| Margaret Glavin, Associate Commissioner of Regulatory Affairs | 10/2/05 | None | Booz-Allen | Booz-Allen Team Feedback to the CTR Survey Results | |
| Margaret Glavin, Associate Commissioner of Regulatory Affairs | 10/19/05 | None | None | National Association of Board of Pharmacy Meeting | |
| Janet Woodcock, M.D. Deputy Commissioner for Operations |
10/19/05 Arlington, VA |
Larry Kessler, CDRH Miriam Provost, CDRH |
Brett Giroir, MD Defense Advanced Research Projects Agency |
Defense Advanced Research Projects Agency
(DARPA) Speaker: General Intro to FDA Critical Path |
|
| Janet Woodcock, M.D. Deputy Commissioner for Operations |
10/21/05 Mayflower Hotel Washington, DC |
Steve Case/John Reher/Gaynor Nichols | ABC2 Annual Meeting Speaker - panel |
||
| Janet Woodcock, M.D. Deputy Commissioner for Operations |
10/26/05 | Doug Throckmorton, CDER | Bio Discovery Online Conference Opportunities for Improving Early Drug Development |
||
| Janet Woodcock, M.D. Deputy Commissioner for Operations |
10/26/05 San Francisco, CA |
George Mills, MD | Dr. Larry Horowitz Stanford University |
Speaker – The Critical Path Initiative: Background, Updates & Next Steps | |
| Sheldon T. Bradshaw, Chief Counsel | 10/17/05 FDA/Rockville, MD | Beverly Chernaik and Mark Raza, OCC | June Austin, Keith Triebwasser, Proctor & Gamble; Ellen Flannery, Covington & Burling | Medical Device Regulations | |
| Sheldon T. Bradshaw, Chief Counsel | 10/18/05 FDA/Washington, DC | None | John Bleder, Jeff Gibbs, Roger Thies, and Frank Sasinowski; Hyman, Phelps & McNamara | Introductory/Courtesy Visit | |
| Sheldon T. Bradshaw, Chief Counsel | 10/20/05 FDA/Washington, DC | None | Wayne Pines, Apco Worldwide | Courtesy | |
| Sheldon T. Bradshaw, Chief Counsel | 10/20/05 FDA/Washington, DC | None | Apco Worldwide Representatives | Introductory/Courtesy Visit | |
| Sheldon T. Bradshaw, Chief Counsel | 10/20/05 FDA/Washington, DC | None | Members of ABA Committee on Health Law Section | Spoke at meeting | |
| Sheldon T. Bradshaw, Chief Counsel | 10/20/05 FDA/Washington, DC | None | Peter Barton Hutt and Scott Cunningham; Covington & Burling | Drug Labeling Issue | |
| Sheldon T. Bradshaw, Chief Counsel | 10/24/05 FDA/Rockville, MD | Bill McConagha, OCC | Rebecca L. Myers, Rotech Healthcare, Inc.; R. Hathaway, John Manthei, Latham & Watkins | Compounding Issues | |
| Jesse L. Goodman, MD, MPH, Director, CBER | 10/25-28/05 Washington, DC | Unknown | Other Participants, names unknown | Participated in Institute of Medicine Workshop, "Protecting Against Foodborne Threats to Health" | |
| Sheldon T. Bradshaw, Chief Counsel | 11/2/05 Washington, DC | None | Board Members of Food and Drug Law Institute | Spoke at Luncheon | |
![]()